Erythrocyte heme‑oxygenation status indicated as a risk factor in prehypertension by Raman spectroscopy

Biochim Biophys Acta Mol Basis Dis. 2018 Nov;1864(11):3659-3663. doi: 10.1016/j.bbadis.2018.07.006. Epub 2018 Jul 6.

Abstract

Raman spectroscopy of erythrocytes provides detailed information about the structure and status of heme moiety, which can be used to provide new insights into molecular pathogenesis of several diseases. In this study, we present the first Raman spectroscopy investigations of the effect of hemoglobin oxygenation in the context of hypertensive disease. The experimental data was subjected to Logistic Regression, which indicated heme‑oxygenation status as an important risk factor alongside other clinical parameters. The 1605/1621 cm-1 band ratio was selected as an optimal Raman metric for risk assessment and along with other band ratios (1583, 1639, 1310 cm-1) related to heme status and when combined with clinical data via logistic regression gave an Area Under the Curve (AUC) >0.95 for prehypertension risk prediction. The work demonstrates the feasibility of Raman spectroscopy to distinguish between prehypertensive and normotensive states. Simultaneously, it is implied that the etiology of the high blood pressure progression may be connected with the changes in hemoglobin oxygenation.

Keywords: Heme oxygenation; Logistic regression; Prehypertension; Raman spectroscopy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Area Under Curve
  • Blood Pressure Monitoring, Ambulatory
  • Disease Progression
  • Erythrocytes / metabolism*
  • Feasibility Studies
  • Healthy Volunteers
  • Heme / chemistry*
  • Humans
  • Logistic Models
  • Models, Biological*
  • Oxyhemoglobins / analysis*
  • Prehypertension / blood
  • Prehypertension / diagnosis*
  • Prehypertension / etiology
  • Risk Assessment / methods
  • Risk Factors
  • Spectrum Analysis, Raman

Substances

  • Oxyhemoglobins
  • Heme